Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID19- Infection with SARS-CoV-2 Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04952519
What this trial is testing

Efficacy of Amantadine Treatment in COVID-19 Patients

Who this might be right for
Patients With Moderate or Severe COVID-19
Noblewell 193
Large-scale testing (Phase 3)Study completedNCT06181292
What this trial is testing

Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine

Who this might be right for
SARS-CoV2 Infection
Hipra Scientific, S.L.U 913
Not applicableLooking for participantsNCT06864156
What this trial is testing

Evaluation of MicroRNAs and Vitamin B12 Expression in Subjects with Neurologic Symptoms of Depression, Anxiety and Fatigue in Long COVID-19

Who this might be right for
Long COVIDLong COVID Syndrome
Instituto Nacional de Rehabilitacion 20
Large-scale testing (Phase 3)Study completedNCT04380519
What this trial is testing

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

Who this might be right for
COVID-19
R-Pharm International, LLC 372
Testing effectiveness (Phase 2)Looking for participantsNCT07157007
What this trial is testing

Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID - 19
Traws Pharma, Inc. 90
Not applicableStudy completedNCT04601012
What this trial is testing

OCTA Study: Retinal Vascular Changes in Patients With SARS-CoV-2 Infection

Who this might be right for
Covid19
Federico II University 40
Post-approval studies (Phase 4)UnknownNCT04912011
What this trial is testing

Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.

Who this might be right for
COVID-19 Pneumonia
Pomeranian Medical University Szczecin 50
Large-scale testing (Phase 3)Ended earlyNCT04894266
What this trial is testing

An Open-Label Study of Apabetalone in Covid Infection

Who this might be right for
COVID-19 Infection
Resverlogix Corp 1
Large-scale testing (Phase 3)UnknownNCT04954092
What this trial is testing

Study of Gam-COVID-Vac in Adolescents

Who this might be right for
Covid19Vaccine Preventable Disease
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 3,000
Not applicableWithdrawnNCT04251767
What this trial is testing

Washed Microbiota Transplantation for Patients With 2019-nCoV Infection

Who this might be right for
COVID-19 Complicated With Refractory Intestinal Infections
The Second Hospital of Nanjing Medical University
Not applicableStudy completedNCT05104411
What this trial is testing

Rehabilitation in Severely Ill Inpatients With COVID-19

Who this might be right for
COVID-19
Seoul National University Bundang Hospital 37
Large-scale testing (Phase 3)UnknownNCT05172037
What this trial is testing

Novaferon in Non-hospitalized Adult Patients With Mild COVID-19

Who this might be right for
Covid19
Genova Inc. 222
Not applicableUnknownNCT04409275
What this trial is testing

LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION

Who this might be right for
Pulmonary Fibrosis
Fundación para la Investigación del Hospital Clínico de Valencia 500
Not applicableStudy completedNCT04568707
What this trial is testing

Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES)

Who this might be right for
Covid19Neurologic ManifestationsPsychiatric Manifestations
Assistance Publique - Hôpitaux de Paris 238
Post-approval studies (Phase 4)UnknownNCT04639375
What this trial is testing

Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19)

Who this might be right for
SARS-CoV-2
E-MO Biology Inc 300
Large-scale testing (Phase 3)UnknownNCT05371522
What this trial is testing

Neuro-inflammation and Post-infectious Fatigue in Individuals With and Without COVID-19

Who this might be right for
COVID-19
Amsterdam UMC, location VUmc 30
Not applicableEnded earlyNCT04569851
What this trial is testing

Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)

Who this might be right for
COVID-19 Infection
Savana Research 100,000
Large-scale testing (Phase 3)UnknownNCT04344431
What this trial is testing

Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19)

Who this might be right for
Covid-19
Direction Centrale du Service de Santé des Armées 100
Not applicableStudy completedNCT05752331
What this trial is testing

Feasibility of Personalised Health Behaviour Coaching to Support Symptoms and Activities of Daily Living in Those With Long COVID-19.

Who this might be right for
Long COVID
Bournemouth University 32
Testing effectiveness (Phase 2)Study completedNCT04405310
What this trial is testing

Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial

Who this might be right for
SARS Pneumonia
Grupo Mexicano para el Estudio de la Medicina Intensiva 42
Next Page